Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting
Aclarion stockholders approved all proposals at the 2026 Annual Meeting, including the election of seven directors and ratification of Haynie & Company as auditor. CEO Brent Ness highlighted 196% year-over-year growth in Nociscan scan volumes in Q1 2026 and expanded insurance coverage in the UK.
Key figures
- Nociscan scan volume growth q1
- 196%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.